Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
I Can Extract Side Effects
Chapter 82

Enzyme Inhibitor, Successful Extraction

1,456 words 5 min read 5 views 4mo ago Source ​
Skip to the end of the chapter
Prev
Next

After seeing Academician Qi off, Wei Kang went to the R&D department.

He summoned Chen Yiqing, Wenren Long, and Tang Que, the three laboratory directors, and informed them of the matter.

Then he looked at Chen Yiqing first and asked her a question.

"Dr. Chen, please give your frank opinion on the task assigned to you by your superiors."

Chen Yiqing frowned, looking at the medical record in her hand over and over again.

After a while, he shook his head and said, "The patient is old and has other diseases such as Hypertension. Even if we develop a new drug, I can't guarantee what the side effects will be. If the elderly person takes it, it may cause other diseases to worsen."

"Moreover, the process of developing a new drug is very long, from identifying the target, to the synthesis and screening of compounds, to safety and toxicology testing, to confirming the administration method, and finally to conducting clinical trials."

"Even if the elderly can participate in clinical trials, that's the last step. The preceding procedures also take time—months or years. No one can guarantee it."

The other two nodded in agreement.

Wei Kang's heart sank, and he continued to ask, "Have you decided on a specific research direction? For example, should we start by eliminating β-amyloid protein deposition, or by focusing on γ-secretase inhibitors? Or perhaps we could change our direction and start with tau protein dephosphorylation? Or even by focusing on immune autophagy cells?"

Wenren Long suddenly whistled and exclaimed in admiration, "Not bad, as expected of the boss. It seems you've done a lot of research. You're very familiar with these cutting-edge research and development trends."

Wei Kang looked over irritably. "We're talking about serious matters, don't interrupt."

Chen Yiqing smiled slightly and continued to introduce the project's research and development direction.

"Nature Reviews Drug Discovery published an article analyzing the development status of failed Alzheimer's disease's drugs up to 2016. The article categorized the mechanisms of action of 59 terminated projects, 88 ongoing projects, and 5 marketed drugs in the AD field into 8 major categories, and then calculated the total R&D investment based on the number of patients recruited for each mechanism and the consumption per patient in each phase of clinical trials."

"The authors found that failed projects were mainly concentrated in the amyloid pathway, Tau protein, neuroimmunity, and neurotransmission. Drugs under development are primarily focused on amyloid protein and Tau. 36% of the projects fall into the category of unclear mechanisms, while there are almost no clinical development projects for mechanisms such as pinocytosis and autophagy."

"As can be seen, most current clinical trials target β-amyloid protein, attempting to break down or prevent the formation of β-amyloid plaques. The project I participated in at Pfizer was also in this direction."

"β-Amyloid protein is a product of γ-secretase hydrolyzing β-amyloid precursor protein (APP). APP can also be hydrolyzed by β-secretase to produce Aβ. Aβ has strong neurotoxic effects after precipitating and accumulating in the cellular matrix. The plaque deposition of this type of protein is closely related to the pathogenesis of Alzheimer's disease. Many drug developments for Alzheimer's disease also directly target β-secretase or γ-secretase."

"Many companies are involved in the research and development of drugs targeting β-secretase or γ-secretase, and many have entered Phase III trials. For example, β-secretase inhibitors include Merck's Verubecestat, Eli Lilly's Lanabesestat, Biogen's Elenbecestat, Johnson & Johnson's Atabecestat, and Novartis' CNP520 (Umibecestat). γ-secretase inhibitors include Myriad's Tarenflurbil and Eli Lilly's Semagacestat."

"However, whether it's the β-secretase inhibitors from Merck, Johnson & Johnson & Novartis, and Novartis, or the γ-secretase inhibitors from Eli Lilly and Myriad, all have ended in failure. This is not the first failure targeting β-amyloid, nor will it be the last."

"Although all new Alzheimer's drugs have failed, every bit of academic research progress will lay the foundation for subsequent drug development, so we don't need to worry unnecessarily, let alone doubt the choice of direction. Differences in the selection of different sites for γ-secretase will also lead to different results in subsequent clinical development."

"We can select new protein targets based on this, improve or synthesize new γ-secretase inhibitor molecular structures to make them more compatible with the targets, thereby achieving therapeutic effects."

Wei Kang nodded and said, "That is indeed a safe direction."

Chen Yiqing was greatly encouraged. "We currently have several pre-selected targets, and we have also constructed new compound molecular formulas, which are being improved. Once the most suitable one is selected, we can proceed with subsequent testing."

Wei Kang looked approvingly at Tang Que, who was standing to the side. The tall, strong man was listening attentively, looking like a well-behaved student, which made Wei Kang feel a little uncomfortable.

After all, Tang Que's appearance was too rugged. He was tall and muscular, with a rough face and various blue tattoos on his hands. It was hard to imagine that a researcher could look like that. Instead, he looked more like a professional killer who had come knocking on the door. When he arrived, the security guard was so scared that he almost called the police.

So he said seriously, "Dr. Chen, Dr. Tang is a Molecular biology. He will help you analyze protein molecules to find suitable targets. If you need the help of a computational chemist, Xiaolong can also use molecular dynamics to dynamically simulate the interaction between drug molecules and protein molecules on a computer."

"In short, with the three of you working together so diligently, we will definitely be able to speed up the project's progress. I look forward to your good news."

After learning about the direction of new drug development, Wei Kang returned to his laboratory.

He began searching the database of discarded medicines with practiced ease.

Since the true cause of Alzheimer's disease is still inconclusive, current research and development efforts are all based on hypotheses.

Therefore, there are many directions for the research and development of new drugs, and he plans to see if there are any suitable side effects that can be extracted.

Perhaps it has side effects on the brain; I don't know if it's effective.

"β-amyloid and tau proteins deposit in the brain, thereby damaging neurons and causing brain atrophy. This leads to several research directions."

"The first is secretase inhibitors, which either enhance the activity of α-secretase or inhibit the activity of β and γ-secretase, both of which can effectively reduce amyloid protein production and achieve the therapeutic goal."

"The second method is to target tau protein, which produces a dephosphorylation effect by increasing the activity of protein phosphatase, thereby restoring abnormal tau protein to normal and thus achieving a therapeutic effect."

"The third method is immunotherapy, which involves actively or passively inducing patients to produce Aβ antibodies, thereby delaying or clearing Aβ accumulation in brain tissue. However, this method carries significant risks and uncertainties. Not every patient can produce enough antibodies, and the immune response can easily become excessive, leading to aseptic meningitis."

"So there are roughly two directions: one is to prevent the deposition of amyloid protein, and the other is to eliminate the amyloid protein that has already been deposited."

"To prevent it, we need secretase inhibitors. To eliminate it, we either need to synthesize small molecule drugs that can precisely bind to the β-amyloid protein target and thus eliminate it, or we need to stimulate the activity and number of autolysosomes through drug action, thereby engulfing the amyloid protein and achieving the effect of elimination."

As Wei Kang pondered, he searched through discarded prescriptions for side effects related to these aspects.

Initially, he searched for drugs to treat encephalitis and brain nerve damage.

Since brain nerve damage is mainly caused by hypoxia and ischemia, these drugs can promote the recovery of vascular nerve function.

Unfortunately, the side effects were not satisfactory to him. They included things like alkalosis, hypokalemia, drooling, facial flushing, vomiting, headache, and rapid heartbeat, which were all pretty useless.

He had no choice but to be patient and carefully look through them one by one.

Suddenly, his eyes lit up.

A completely unexpected prescription appeared before him.

"A small molecule drug for treating Acne paradox was originally intended to treat follicular hyperkeratosis, but it was very ineffective and actually worsened the Acne inflammation after use, so it was discontinued."

"Because one of the components, present in trace amounts, can inhibit the production of gamma secretase, leading to a deficiency of gamma secretase, which in turn causes a malignant reaction and stimulates the formation of abscesses on the skin."

"It turns out that the lack of gamma secretase can lead to this result. That makes sense, since Acne is more common in young people, they certainly don't have amyloid deposits in their brains."

"This side effect is exactly what I wanted."

"The system extracts the side effects of inhibiting gamma secretase and generates new drugs."

It's going to be available tomorrow, but today I got a triple dose of blocked chapters. It's enough to make me want to cry.

I applied for the lifting of the ban, but I don't know when it will be possible.

Thank you Meteor Cat for the 100-coin reward, and thank you to all the readers for your support.

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Wei Kang

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS